Quisitive and Inform Diagnostics Partner to Develop Real-Time Biopsy Tracking Solution
TORONTO and IRVING, Texas -- July 9, 2020 -- NewsGenie -- Quisitive Technology Solutions and Inform Diagnostics have announced an agreement to expand their relationship to develop a real-time, biopsy tracking solution. The collaboration will produce a mobile application powered by Microsoft Azure, Azure AI, and Microsoft Teams, providing clinicians with real-time information.
This project builds on Quisitive’s and Inform Diagnostics’ work over the past 18 months to modernize Inform Diagnostics’ IT infrastructure. The new IT infrastructure will be fully deployed across Inform Diagnostics’ labs by year end, including the Phoenix lab providing COVID-19 molecular testing.
Nancy Gay, President and COO at Inform Diagnostics, stated that the work with Quisitive and Microsoft facilitated easier integration of lab and technology changes, with the goal of improving the clinicians’ experience.
The mobile application will provide clinicians with end-to-end, real-time tracking of their patients’ biopsies with 24/7 access to information.
Mike Reinhart, CEO of Quisitive, noted that Inform Diagnostics' modern cloud infrastructure allows them to expedite the development of this new solution. Patty Obermaier, Vice President, U.S. Health & Life Sciences at Microsoft Corp, noted that Quisitive is a valuable resource for companies like Inform Diagnostics.
Quisitive will license the mobile application to Inform Diagnostics and use the technology to improve patient care across the healthcare ecosystem.
Inform Diagnostics provides clinicians and their patients with subspecialty pathology services. Quisitive is a Microsoft solutions provider that helps enterprise organizations move, operate, and innovate in the Microsoft cloud.